Type II transmembrane serine protease (TTSP) deregulation in cancer

Frontiers in Bioscience

Volumn 16, Issue 2, 2011, Pages 539-552

  Webb, Siobhan L ^a   Sanders, Andrew J ^a   Mason, Malcolm D ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Cancer; Protease; Review; TMPRSS; Transmembrane; TTSP

Indexed keywords

CORIN PROTEIN, HUMAN; DESC1 PROTEIN, HUMAN; HEPSIN; HUMAN AIRWAY TRYPSIN LIKE PROTEASE; HUMAN AIRWAY TRYPSIN-LIKE PROTEASE; MATRIPTASE; MATRIPTASE 2; MEMBRANE PROTEIN; SERINE PROTEINASE; TMPRSS2 PROTEIN, HUMAN; TMPRSS3 PROTEIN, HUMAN; TRANSMEMBRANE SERINE PROTEASE 2, HUMAN; TUMOR PROTEIN;

ANIMAL; ENZYMOLOGY; HUMAN; MALE; MOUSE; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; REVIEW;

ANIMALS; HUMANS; MALE; MEMBRANE PROTEINS; MICE; NEOPLASM PROTEINS; NEOPLASMS; PROSTATIC NEOPLASMS; SERINE ENDOPEPTIDASES;

EID: 79955022479     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3704     Document Type: Article

References (128)

1. E.S. Lander, L.M. Linton, B. Birren, C. Nusbaum, M.C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. Gage, K. Harris, A. Heaford, J. Howland, L. Kann, J. Lehoczky, R. LeVine, P. McEwan, K. McKernan, J. Meldrim, J.P. Mesirov, C. Miranda, W. Morris, J. Naylor, C. Raymond, M. Rosetti, R. Santos, A. Sheridan, C. Sougnez, N. Stange-Thomann, N. Stojanovic, A. Subramanian, D. Wyman, J. Rogers, J. Sulston, R. Ainscough, S. Beck, D. Bentley, J. Burton, C. Clee, N. Carter, A. Coulson, R. Deadman, P. Deloukas, A. Dunham, I. Dunham, R. Durbin, L. French, D. Grafham, S. Gregory, T. Hubbard, S. Humphray, A. Hunt, M. Jones, C. Lloyd, A. McMurray, L. Matthews, S. Mercer, S. Milne, J.C. Mullikin, A. Mungall, R. Plumb, M. Ross, R. Shownkeen, S. Sims, R.H. Waterston, R.K. Wilson, L.W. Hillier, J.D. McPherson, M.A. Marra, E.R. Mardis, L.A. Fulton, A.T. Chinwalla, K.H. Pepin, W.R. Gish, S.L. Chissoe, M.C. Wendl, K.D. Delehaunty, T.L. Miner, A. Delehaunty, J.B. Kramer, L.L. Cook, R.S. Fulton, D.L. Johnson, P.J. Minx, S.W. Clifton, T. Hawkins, E. Branscomb, P. Predki, P. Richardson, S. Wenning, T. Slezak, N. Doggett, J.F. Cheng, A. Olsen, S. Lucas, C. Elkin, E. Uberbacher, M. Frazier, R.A. Gibbs, D.M. Muzny, S.E. Scherer, J.B. Bouck, E.J. Sodergren, K.C. Worley, C.M. Rives, J.H. Gorrell, M.L. Metzker, S.L. Naylor, R.S. Kucherlapati, D.L. Nelson, G.M. Weinstock, Y. Sakaki, A. Fujiyama, M. Hattori, T. Yada, A. Toyoda, T. Itoh, C. Kawagoe, H. Watanabe, Y. Totoki, T. Taylor, J. Weissenbach, R. Heilig, W. Saurin, F. Artiguenave, P. Brottier, T. Bruls, E. Pelletier, C. Robert, P. Wincker, D.R. Smith, L. Doucette-Stamm, M. Rubenfield, K. Weinstock, H.M. Lee, J. Dubois, A. Rosenthal, M. Platzer, G. Nyakatura, S. Taudien, A. Rump, H. Yang, J. Yu, J. Wang, G. Huang, J. Gu, L. Hood, L. Rowen, A. Madan, S. Qin, R.W. Davis, N.A. Federspiel, A.P. Abola, M.J. Proctor, R.M. Myers, J. Schmutz, M. Dickson, J. Grimwood, D.R. Cox, M.V. Olson, R. Kaul, N. Shimizu, K. Kawasaki, S. Minoshima, G.A. Evans, M. Athanasiou, R. Schultz, B.A. Roe, F. Chen, H. Pan, J. Ramser, H. Lehrach, R. Reinhardt, W.R. McCombie, M. de la Bastide, N. Dedhia, H. Blocker, K. Hornischer, G. Nordsiek, R. Agarwala, L. Aravind, J.A. Bailey, A. Bateman, S. Batzoglou, E. Birney, P. Bork, D.G. Brown, C.B. Burge, L. Cerutti, H.C. Chen, D. Church, M. Clamp, R.R. Copley, T. Doerks, S.R. Eddy, E.E. Eichler, T.S. Furey, J. Galagan, J.G. Gilbert, C. Harmon, Y. Hayashizaki, D. Haussler, H. Hermjakob, K. Hokamp, W. Jang, L.S. Johnson, T.A. Jones, S. Kasif, A. Kaspryzk, S. Kennedy, W.J. Kent, P. Kitts, E.V. Koonin, I. Korf, D. Kulp, D. Lancet, T.M. Lowe, A. McLysaght, T. Mikkelsen, J.V. Moran, N. Mulder, V.J. Pollara, C.P. Ponting, G. Schuler, J. Schultz, G. Slater, A.F. Smit, E. Stupka, J. Szustakowski, D. Thierry-Mieg, J. Thierry-Mieg, L. Wagner, J. Wallis, R. Wheeler, A. Williams, Y.I. Wolf, K.H. Wolfe, S.P. Yang, R.F. Yeh, F. Collins, M.S. Guyer, J. Peterson, A. Felsenfeld, K.A. Wetterstrand, A. Patrinos, M.J. Morgan, P. de Jong, J.J. Catanese, K. Osoegawa, H. Shizuya, S. Choi and Y.J. Chen: Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001) (Pubitemid 32165345)
2. R. Szabo and T.H. Bugge: Type II transmembrane serine proteases in development and disease. Int J Biochem Cell Biol 40, 1297-1316 (2008)
3. N.D. Rawlings and A.J. Barrett: Families of serine peptidases. Methods Enzymol 244, 19-61 (1994)
4. G.W. Wong, Y. Tang, E. Feyfant, A. Sali, L. Li, Y. Li, C. Huang, D.S. Friend, S.A. Krilis, and R.L. Stevens: Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension. J Biol Chem 274, 30784-30793 (1999)
5. J.D. Hooper, J.A. Clements, J.P. Quigley, and T.M. Antalis: Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem 276, 857-860 (2001) (Pubitemid 32096501)
6. S. Netzel-Arnett, J.D. Hooper, R. Szabo, E.L. Madison, J.P. Quigley, T.H. Bugge, and T.M. Antalis: Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev 22, 237-258 (2003) (Pubitemid 36561060)
7. D. Maestracci, H. Preiser, T. Hedges, J. Schmitz, and R.K. Crane: Enzymes of the human intestinal brush border membrane. Identification after gel electrophoretic separation. Biochim Biophys Acta 382, 147-156 (1975)
8. C.Y. Lin, J. Anders, M. Johnson, Q.A. Sang, and R.B. Dickson: Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem 274, 18231-18236 (1999)
9. C.Y. Lin, J.K. Wang, J. Torri, L. Dou, Q.A. Sang, and R.B. Dickson: Characterization of a novel, membranebound, 80-kDa matrix-degrading protease from human breast cancer cells. Monoclonal antibody production, isolation, and localization. J Biol Chem 272, 9147-9152 (1997) (Pubitemid 27154920)
10. G. Velasco, S. Cal, V. Quesada, L.M. Sanchez, and C. Lopez-Otin: Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem 277, 37637-37646 (2002)
11. R. Szabo, S. Netzel-Arnett, J.P. Hobson, T.M. Antalis, and T.H. Bugge: Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity. Biochem J 390, 231-242 (2005) (Pubitemid 41192249)
12. S.P. Leytus, K.R. Loeb, F.S. Hagen, K. Kurachi, and E.W. Davie: A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry 27, 1067-1074 (1988) (Pubitemid 18053001)
13. A. Tsuji, A. Torres-Rosado, T. Arai, S.H. Chou, and K. Kurachi: Characterization of hepsin, a membrane bound protease. Biomed Biochim Acta 50, 791-793 (1991)
14. A. Tsuji, A. Torres-Rosado, T. Arai, M.M. Le Beau, R.S. Lemons, S.H. Chou, and K. Kurachi: Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J Biol Chem 266, 16948-16953 (1991)
15. A. Paoloni-Giacobino, H. Chen, M.C. Peitsch, C. Rossier, and S.E. Antonarakis: Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics 44, 309-320 (1997) (Pubitemid 27419006)
16. H.S. Scott, J. Kudoh, M. Wattenhofer, K. Shibuya, A. Berry, R. Chrast, M. Guipponi, J. Wang, K. Kawasaki, S. Asakawa, S. Minoshima, F. Younus, S.Q. Mehdi, U. Radhakrishna, M.P. Papasavvas, C. Gehrig, C. Rossier, M. Korostishevsky, A. Gal, N. Shimizu, B. Bonne-Tamir, and S.E. Antonarakis: Insertion of beta-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness. Nat Genet 27, 59-63 (2001) (Pubitemid 32044519)
17. C. Wallrapp, S. Hahnel, F. Muller-Pillasch, B. Burghardt, T. Iwamura, M. Ruthenburger, M.M. Lerch, G. Adler, and T.M. Gress: A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer Cancer Res 60, 2602-2606 (2000) (Pubitemid 30318232)
18. N. Yamaguchi, A. Okui, T. Yamada, H. Nakazato, and S. Mitsui: Spinesin/TMPRSS5, a novel transmembrane serine protease, cloned from human spinal cord. J Biol Chem 277, 6806-6812 (2002) (Pubitemid 34953062)
19. M. Hayama, Y. Okumura, E. Takahashi, A. Shimabukuro, M. Tamura, N. Takeda, T. Kubo, and H. Kido: Identification and analysis of the promoter region of the type II transmembrane serine protease polyserase-1 and its transcript variants. Biol Chem 388, 853-858 (2007) (Pubitemid 47184844)
20. W. Yan, N. Sheng, M. Seto, J. Morser, and Q. Wu: Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem 274, 14926-14935 (1999)
21. J.C. Lang and D.E. Schuller: Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck. Br J Cancer 84, 237-243 (2001) (Pubitemid 32113452)
22. K. Yamaoka, K. Masuda, H. Ogawa, K. Takagi, N. Umemoto, and S. Yasuoka: Cloning and characterization of the cDNA for human airway trypsin-like protease. J Biol Chem 273, 11895-11901 (1998) (Pubitemid 28272097)
23. R. Szabo, Q. Wu, R.B. Dickson, S. Netzel-Arnett, T.M. Antalis, and T.H. Bugge: Type II transmembrane serine proteases. Thromb Haemost 90, 185-193 (2003) (Pubitemid 36992495)
24. S.Y. Choi, S. Bertram, I. Glowacka, Y.W. Park, and S. Pohlmann: Type II transmembrane serine proteases in cancer and viral infections. Trends Mol Med 15, 303-312 (2009)
25. M. Del Rosso, G. Fibbi, M. Pucci, S. D'Alessio, A. Del Rosso, L. Magnelli, and V. Chiarugi: Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin Exp Metastasis 19, 193-207 (2002) (Pubitemid 34553521)
26. C. Lopez-Otin and L.M. Matrisian: Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7, 800-808 (2007) (Pubitemid 47463671)
27. C.Y. Lin, J. Anders, M. Johnson, and R.B. Dickson: Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 274, 18237-18242 (1999)
28. D. Louvard, S. Maroux, J. Baratti, and P. Desnuelle: On the distribution of enterokinase in porcine intestine and on its subcellular localization. Biochim Biophys Acta 309, 127-137 (1973)
29. D.E. Afar, I. Vivanco, R.S. Hubert, J. Kuo, E. Chen, D.C. Saffran, A.B. Raitano, and A. Jakobovits: Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Res 61, 1686-1692 (2001) (Pubitemid 34292606)
30. C. Abate-Shen and M.M. Shen: Molecular genetics of prostate cancer. Genes Dev 14, 2410-2434 (2000)
31. V.L. Robinson, E.C. Kauffman, M.H. Sokoloff, and C.W. Rinker-Schaeffer: The basic biology of metastasis. Cancer Treat Res 118, 1-21 (2004)
32. C. Chang and Z. Werb: The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11, S37-43 (2001)
33. M.D. Oberst, B. Singh, M. Ozdemirli, R.B. Dickson, M.D. Johnson, and C.Y. Lin: Characterization of matriptase expression in normal human tissues. J Histochem Cytochem 51, 1017-1025 (2003) (Pubitemid 36919979)
34. T. Takeuchi, J.L. Harris, W. Huang, K.W. Yan, S.R. Coughlin, and C.S. Craik: Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinasetype plasminogen activator as substrates. J Biol Chem 275, 26333-26342 (2000)
35. K. Uhland: Matriptase and its putative role in cancer. Cell Mol Life Sci 63, 2968-2978 (2006) (Pubitemid 46072302)
36. M.D. Oberst, C.A. Williams, R.B. Dickson, M.D. Johnson, and C.Y. Lin: The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J Biol Chem 278, 26773-26779 (2003) (Pubitemid 36876825)
37. Y. Miyake, S. Tsuzuki, T. Fushiki, and K. Inouye: Matriptase does not require hepatocyte growth factor activator inhibitor type-1 for activation in an epithelial cell expression model. Biosci Biotechnol Biochem 74, 848-850 (2010)
38. Y.E. Shi, J. Torri, L. Yieh, A. Wellstein, M.E. Lippman, and R.B. Dickson: Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells. Cancer Res 53, 1409-1415 (1993) (Pubitemid 23097125)
39. J.S. Jin, D.S. Hsieh, S.H. Loh, A. Chen, C.W. Yao, and C.Y. Yen: Increasing expression of serine protease matriptase in ovarian tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters. Mod Pathol 19, 447-452 (2006) (Pubitemid 43276999)
40. M. Kobel, S.E. Kalloger, N. Boyd, S. McKinney, E. Mehl, C. Palmer, S. Leung, N.J. Bowen, D.N. Ionescu, A. Rajput, L.M. Prentice, D. Miller, J. Santos, K. Swenerton, C.B. Gilks, and D. Huntsman: Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 5, e232 (2008)
41. W.C. Tsai, C.H. Chu, C.P. Yu, L.F. Sheu, A. Chen, H. Chiang, and J.S. Jin: Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers 24, 89-99 (2008)
42. M.R. Darragh, E.L. Schneider, J. Lou, P.J. Phojanakong, C.J. Farady, J.D. Marks, B.C. Hann, and C.S. Craik: Tumor detection by imaging proteolytic activity. Cancer Res 70, 1505-1512 (2010)
43. S.L. Lee, R.B. Dickson, and C.Y. Lin: Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 275, 36720-36725 (2000) (Pubitemid 32002078)
44. X. Jin, M. Yagi, N. Akiyama, T. Hirosaki, S. Higashi, C.Y. Lin, R.B. Dickson, H. Kitamura, and K. Miyazaki: Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis. Cancer Sci 97, 1327-1334 (2006) (Pubitemid 44614984)
45. G. Bocheva, A. Rattenholl, C. Kempkes, T. Goerge, C.Y. Lin, M.R. D'Andrea, S. Stander, and M. Steinhoff: Role of matriptase and proteinase-activated receptor-2 in nonmelanoma skin cancer. J Invest Dermatol 129, 1816-1823 (2009)
46. K. List, R. Szabo, A. Molinolo, V. Sriuranpong, V. Redeye, T. Murdock, B. Burke, B.S. Nielsen, J.S. Gutkind, and T.H. Bugge: Deregulated matriptase causes rasindependent multistage carcinogenesis and promotes rasmediated malignant transformation. Genes Dev 19, 1934-1950 (2005) (Pubitemid 41186993)
47. H. Cheng, T. Fukushima, N. Takahashi, H. Tanaka, and H. Kataoka: Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases. Cancer Res 69, 1828-1835 (2009)
48. L.K. Vogel, M. Saebo, C.F. Skjelbred, K. Abell, E.D. Pedersen, U. Vogel, and E.H. Kure: The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals. BMC Cancer 6, 176 (2006)
49. M.D. Oberst, M.D. Johnson, R.B. Dickson, C.Y. Lin, B. Singh, M. Stewart, A. Williams, A. al-Nafussi, J.F. Smyth, H. Gabra, and G.C. Sellar: Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin Cancer Res 8, 1101-1107 (2002) (Pubitemid 35177362)
50. J.D. Hooper, L. Campagnolo, G. Goodarzi, T.N. Truong, H. Stuhlmann, and J.P. Quigley: Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues. Biochem J 373, 689-702 (2003) (Pubitemid 36981079)
51. F. Beliveau, A. Desilets, and R. Leduc: Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides. FEBS J 276, 2213-2226 (2009)
52. L. Silvestri, A. Pagani, A. Nai, I. De Domenico, J. Kaplan, and C. Camaschella: The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 8, 502-511 (2008)
53. F. Odet, A. Verot, and B. Le Magueresse-Battistoni: The mouse testis is the source of various serine proteases and serine proteinase inhibitors (SERPINs): Serine proteases and SERPINs identified in Leydig cells are under gonadotropin regulation. Endocrinology 147, 4374-4383 (2006) (Pubitemid 44268388)
54. C.M. Overall, E.M. Tam, R. Kappelhoff, A. Connor, T. Ewart, C.J. Morrison, X. Puente, C. Lopez-Otin, and A. Seth: Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol Chem 385, 493-504 (2004) (Pubitemid 38967777)
55. C. Parr, A.J. Sanders, G. Davies, T. Martin, J. Lane, M.D. Mason, R.E. Mansel, and W.G. Jiang: Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Clin Cancer Res 13, 3568-3576 (2007) (Pubitemid 46955117)
56. A.J. Sanders, C. Parr, T.A. Martin, J. Lane, M.D. Mason, and W.G. Jiang: Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation. J Cell Physiol 216, 780-789 (2008)
57. A.J. Sanders, S.L. Webb, C. Parr, M.D. Mason, and W.G. Jiang: The type II transmembrane serine protease, matriptase-2: Possible links to cancer? Anticancer Agents Med Chem 10, 64-69 (2010)
58. T.R. Adib, S. Henderson, C. Perrett, D. Hewitt, D. Bourmpoulia, J. Ledermann, and C. Boshoff: Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer 90, 686-692 (2004) (Pubitemid 38297211)
59. Z. Chen, Z. Fan, J.E. McNeal, R. Nolley, M.C. Caldwell, M. Mahadevappa, Z. Zhang, J.A. Warrington, and T.A. Stamey: Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. J Urol 169, 1316-1319 (2003) (Pubitemid 36323775)
60. S.M. Dhanasekaran, T.R. Barrette, D. Ghosh, R. Shah, S. Varambally, K. Kurachi, K.J. Pienta, M.A. Rubin, and A.M. Chinnaiyan: Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822-826 (2001) (Pubitemid 32801464)
61. S. Herter, D.E. Piper, W. Aaron, T. Gabriele, G. Cutler, P. Cao, A.S. Bhatt, Y. Choe, C.S. Craik, N. Walker, D. Meininger, T. Hoey, and R.J. Austin: Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem J 390, 125-136 (2005) (Pubitemid 41192238)
62. K. Huppi and G.V. Chandramouli: Molecular profiling of prostate cancer. Curr Urol Rep 5, 45-51 (2004)
63. Y. Lai, B. Wu, L. Chen, and H. Zhao: A statistical method for identifying differential gene-gene co-expression patterns. Bioinformatics 20, 3146-3155 (2004) (Pubitemid 39619204)
64. J. Luo, D.J. Duggan, Y. Chen, J. Sauvageot, C.M. Ewing, M.L. Bittner, J.M. Trent, and W.B. Isaacs: Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 61, 4683-4688 (2001) (Pubitemid 32691876)
65. J.A. Magee, T. Araki, S. Patil, T. Ehrig, L. True, P.A. Humphrey, W.J. Catalona, M.A. Watson, and J. Milbrandt: Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 61, 5692-5696 (2001) (Pubitemid 32769078)
66. D.R. Rhodes, T.R. Barrette, M.A. Rubin, D. Ghosh, and A.M. Chinnaiyan: Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res 62, 4427-4433 (2002) (Pubitemid 34827303)
67. T.A. Stamey, J.A. Warrington, M.C. Caldwell, Z. Chen, Z. Fan, M. Mahadevappa, J.E. McNeal, R. Nolley, and Z. Zhang: Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol 166, 2171-2177 (2001) (Pubitemid 33065250)
68. H. Tanimoto, Y. Yan, J. Clarke, S. Korourian, K. Shigemasa, T.H. Parmley, G.P. Parham, and T.J. O'Brien: Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res 57, 2884-2887 (1997) (Pubitemid 27315033)
69. J.B. Welsh, L.M. Sapinoso, A.I. Su, S.G. Kern, J. Wang-Rodriguez, C.A. Moskaluk, H.F. Frierson, Jr., and G.M. Hampton: Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61, 5974-5978 (2001) (Pubitemid 32762523)
70. Q. Wu and G. Parry: Hepsin and prostate cancer. Front Biosci 12, 5052-5059 (2007)
71. H. Betsunoh, S. Mukai, Y. Akiyama, T. Fukushima, N. Minamiguchi, Y. Hasui, Y. Osada, and H. Kataoka: Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma. Cancer Sci 98, 491-498 (2007) (Pubitemid 46562738)
72. L.R. Zacharski, D.L. Ornstein, V.A. Memoli, S.M. Rousseau, and W. Kisiel: Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma. Thromb Haemost 79, 876-877 (1998)
73. T. Matsuo, K. Nakamura, N. Takamoto, J. Kodama, A. Hongo, F. Abrzua, Y. Nasu, H. Kumon, and Y. Hiramatsu: Expression of the serine protease hepsin and clinical outcome of human endometrial cancer. Anticancer Res 28, 159-164 (2008) (Pubitemid 351362896)
74. H.C. Huang, S. Zheng, V. VanBuren, and Z. Zhao: Discovering disease-specific biomarker genes for cancer diagnosis and prognosis. Technol Cancer Res Treat 9, 219-230 (2010)
75. E.S. Leman, A. Magheli, K.M. Yong, G. Netto, S. Hinz, and R.H. Getzenberg: Identification of nuclear structural protein alterations associated with seminomas. J Cell Biochem 108, 1274-1279 (2009)
76. D.J. Parekh, D.P. Ankerst, D. Troyer, S. Srivastava, and I.M. Thompson: Biomarkers for prostate cancer detection. J Urol 178, 2252-2259 (2007) (Pubitemid 350052199)
77. G. Sardana, B. Dowell, and E.P. Diamandis: Emerging biomarkers for the diagnosis and prognosis of prostate cancer. Clin Chem 54, 1951-1960 (2008) (Pubitemid 352774027)
78. V.N. Talesa, C. Antognelli, C. Del Buono, F. Stracci, M.R. Serva, E. Cottini, and E. Mearini: Diagnostic potential in prostate cancer of a panel of urinary molecular tumor markers. Cancer Biomark 5, 241-251 (2009)
79. S.K. Holt, E.M. Kwon, D.W. Lin, E.A. Ostrander, and J.L. Stanford: Association of hepsin gene variants with prostate cancer risk and prognosis. Prostate (2010)
80. O. Klezovitch, J. Chevillet, J. Mirosevich, R.L. Roberts, R.J. Matusik, and V. Vasioukhin: Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6, 185-195 (2004) (Pubitemid 39485690)
81. K.A. Owen, D. Qiu, J. Alves, A.M. Schumacher, L.M. Kilpatrick, J. Li, J.L. Harris, and V. Ellis: Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA. Biochem J 426, 219-228 (2010)
82. D. Qiu, K. Owen, K. Gray, R. Bass, and V. Ellis: Roles and regulation of membrane-associated serine proteases. Biochem Soc Trans 35, 583-587 (2007) (Pubitemid 46975081)
83. W. Li, B.E. Wang, P. Moran, T. Lipari, R. Ganesan, R. Corpuz, M.J. Ludlam, A. Gogineni, H. Koeppen, S. Bunting, W.Q. Gao, and D. Kirchhofer: Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis. Cancer Res 69, 8395-8402 (2009)
84. M. Tripathi, S. Nandana, H. Yamashita, R. Ganesan, D. Kirchhofer, and V. Quaranta: Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression. J Biol Chem 283, 30576-30584 (2008)
85. P. Moran, W. Li, B. Fan, R. Vij, C. Eigenbrot, and D. Kirchhofer: Pro-urokinase-type plasminogen activator is a substrate for hepsin. J Biol Chem 281, 30439-30446 (2006) (Pubitemid 44596152)
86. S. Wilson, B. Greer, J. Hooper, A. Zijlstra, B. Walker, J. Quigley, and S. Hawthorne: The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. Biochem J 388, 967-972 (2005) (Pubitemid 40941585)
87. T.H. Rabbitts: Chromosomal translocations in human cancer. Nature 372, 143-149 (1994) (Pubitemid 24347832)
88. A. de Klein, A.G. van Kessel, G. Grosveld, C.R. Bartram, A. Hagemeijer, D. Bootsma, N.K. Spurr, N. Heisterkamp, J. Groffen, and J.R. Stephenson: A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300, 765-767 (1982) (Pubitemid 13224358)
89. J.D. Rowley: Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290-293 (1973)
90. V.J. Scheble, M. Braun, R. Beroukhim, C.H. Mermel, C. Ruiz, T. Wilbertz, A.C. Stiedl, K. Petersen, M. Reischl, R. Kuefer, D. Schilling, F. Fend, G. Kristiansen, M. Meyerson, M.A. Rubin, L. Bubendorf, and S. Perner: ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor. Mod Pathol (2010)
91. G. Petrovics, A. Liu, S. Shaheduzzaman, B. Furusato, C. Sun, Y. Chen, M. Nau, L. Ravindranath, A. Dobi, V. Srikantan, I.A. Sesterhenn, D.G. McLeod, M. Vahey, J.W. Moul, and S. Srivastava: Frequent overexpression of ETSrelated gene-1 (ERG1) in prostate cancer transcriptome. Oncogene 24, 3847-3852 (2005) (Pubitemid 40826884)
92. S.A. Tomlins, D.R. Rhodes, S. Perner, S.M. Dhanasekaran, R. Mehra, X.W. Sun, S. Varambally, X. Cao, J. Tchinda, R. Kuefer, C. Lee, J.E. Montie, R.B. Shah, K.J. Pienta, M.A. Rubin, and A.M. Chinnaiyan: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644-648 (2005) (Pubitemid 41528150)
93. A. Seth and D.K. Watson: ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 41, 2462-2478 (2005) (Pubitemid 41540623)
94. J. Wang, Y. Cai, W. Yu, C. Ren, D.M. Spencer, and M. Ittmann: Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts. Cancer Res 68, 8516-8524 (2008)
95. B.S. Carver, J. Tran, Z. Chen, A. Carracedo-Perez, A. Alimonti, C. Nardella, A. Gopalan, P.T. Scardino, C. Cordon-Cardo, W. Gerald, and P.P. Pandolfi: ETS rearrangements and prostate cancer initiation. Nature 457, E1; discussion E2-3 (2009)
96. W. Huang and M. Waknitz: ETS gene fusions and prostate cancer. Am J Transl Res 1, 341-351 (2009)
97. T.S. Kim, C. Heinlein, R.C. Hackman, and P.S. Nelson: Phenotypic analysis of mice lacking the Tmprss2-encoded protease. Mol Cell Biol 26, 965-975 (2006) (Pubitemid 43146490)
98. B. Han, R. Mehra, S.M. Dhanasekaran, J. Yu, A. Menon, R.J. Lonigro, X. Wang, Y. Gong, L. Wang, S. Shankar, B. Laxman, R.B. Shah, S. Varambally, N. Palanisamy, S.A. Tomlins, C. Kumar-Sinha, and A.M. Chinnaiyan: A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. Cancer Res 68, 7629-7637 (2008)
99. D. Hessels, F.P. Smit, G.W. Verhaegh, J.A. Witjes, E.B. Cornel, and J.A. Schalken: Detection of TMPRSS2- ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clin Cancer Res 13, 5103-5108 (2007) (Pubitemid 47502077)
100. B. Laxman, S.A. Tomlins, R. Mehra, D.S. Morris, L. Wang, B.E. Helgeson, R.B. Shah, M.A. Rubin, J.T. Wei, and A.M. Chinnaiyan: Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Neoplasia 8, 885-888 (2006)
101. S.A. Tomlins, A. Bjartell, A.M. Chinnaiyan, G. Jenster, R.K. Nam, M.A. Rubin, and J.A. Schalken: ETS gene fusions in prostate cancer: from discovery to daily clinical practice. Eur Urol 56, 275-286 (2009)
102. D.L. Cao and X.D. Yao: Advances in biomarkers for the early diagnosis of prostate cancer. Chin J Cancer 29, 229-233 (2010)
103. K.R. Rice, Y. Chen, A. Ali, E.J. Whitman, A. Blase, M. Ibrahim, S. Elsamanoudi, S. Brassell, B. Furusato, N. Stingle, I.A. Sesterhenn, G. Petrovics, S. Miick, H. Rittenhouse, J. Groskopf, D.G. McLeod, and S. Srivastava: Evaluation of the ETS-related gene mRNA in urine for the detection of prostate cancer. Clin Cancer Res 16, 1572-1576 (2010)
104. L.J. Underwood, K. Shigemasa, H. Tanimoto, J.B. Beard, E.N. Schneider, Y. Wang, T.H. Parmley, and T.J. O'Brien: Ovarian tumor cells express a novel multi-domain cell surface serine protease. Biochim Biophys Acta 1502, 337-350 (2000)
105. T. Sawasaki, K. Shigemasa, L. Gu, J.B. Beard, and T.J. O'Brien: The transmembrane protease serine (TMPRSS3/TADG-12) D variant: a potential candidate for diagnosis and therapeutic intervention in ovarian cancer. Tumour Biol 25, 141-148 (2004) (Pubitemid 39274283)
106. S. Bellone, S. Anfossi, T.J. O'Brien, M.J. Cannon, D.A. Silasi, M. Azodi, P.E. Schwartz, T.J. Rutherford, S. Pecorelli, and A.D. Santin: Induction of human tumorassociated differentially expressed gene-12 (TADG- 12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer. Cancer 115, 800-811 (2009)
107. H. Jung, K.P. Lee, S.J. Park, J.H. Park, Y.S. Jang, S.Y. Choi, J.G. Jung, K. Jo, D.Y. Park, J.H. Yoon, D.S. Lim, G.R. Hong, C. Choi, Y.K. Park, J.W. Lee, H.J. Hong, S. Kim, and Y.W. Park: TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene 27, 2635-2647 (2008) (Pubitemid 351550879)
108. A.I. Riker, S.A. Enkemann, O. Fodstad, S. Liu, S. Ren, C. Morris, Y. Xi, P. Howell, B. Metge, R.S. Samant, L.A. Shevde, W. Li, S. Eschrich, A. Daud, J. Ju, and J. Matta: The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 1, 13 (2008)
109. B. Jarzab, M. Wiench, K. Fujarewicz, K. Simek, M. Jarzab, M. Oczko-Wojciechowska, J. Wloch, A. Czarniecka, E. Chmielik, D. Lange, A. Pawlaczek, S. Szpak, E. Gubala, and A. Swierniak: Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res 65, 1587-1597 (2005) (Pubitemid 40270189)
110. E. Kebebew, M. Peng, E. Reiff, Q.Y. Duh, O.H. Clark, and A. McMillan: ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg 242, 353-361; discussion 361-353 (2005)
111. E. Kebebew, M. Peng, E. Reiff, and A. McMillan: Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer 106, 2592-2597 (2006)
112. G. Dawelbait, C. Winter, Y. Zhang, C. Pilarsky, R. Grutzmann, J.C. Heinrich, and M. Schroeder: Structural templates predict novel protein interactions and targets from pancreas tumour gene expression data. Bioinformatics 23, i115-124 (2007) (Pubitemid 47244392)
113. S. Kim, H.Y. Kang, E.H. Nam, M.S. Choi, X.F. Zhao, C.S. Hong, J.W. Lee, J.H. Lee, and Y.K. Park: TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways. Carcinogenesis 31, 597-606 (2010)
114. S. Yasuoka, T. Ohnishi, S. Kawano, S. Tsuchihashi, M. Ogawara, K. Masuda, K. Yamaoka, M. Takahashi, and T. Sano: Purification, characterization, and localization of a novel trypsin-like protease found in the human airway. Am J Respir Cell Mol Biol 16, 300-308 (1997) (Pubitemid 127497453)
115. S. Hahner, M. Fassnacht, F. Hammer, M. Schammann, D. Weismann, I.A. Hansen, and B. Allolio: Evidence against a role of human airway trypsin-like protease-the human analogue of the growth-promoting rat adrenal secretory protease-in adrenal tumourigenesis. Eur J Endocrinol 152, 143-153 (2005) (Pubitemid 40185463)
116. I.A. Hansen, M. Fassnacht, S. Hahner, F. Hammer, M. Schammann, S.R. Meyer, A.B. Bicknell, and B. Allolio: The adrenal secretory serine protease AsP is a short secretory isoform of the transmembrane airway trypsin-like protease. Endocrinology 145, 1898-1905 (2004) (Pubitemid 38402399)
117. K. Iwakiri, M. Ghazizadeh, E. Jin, M. Fujiwara, T. Takemura, S. Takezaki, S. Kawana, S. Yasuoka, and O. Kawanami: Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris. J Invest Dermatol 122, 937-944 (2004) (Pubitemid 38580996)
118. M. Chokki, S. Yamamura, H. Eguchi, T. Masegi, H. Horiuchi, H. Tanabe, T. Kamimura, and S. Yasuoka: Human airway trypsin-like protease increases mucin gene expression in airway epithelial cells. Am J Respir Cell Mol Biol 30, 470-478 (2004) (Pubitemid 38457180)
119. S. Yoshinaga, Y. Nakahori, and S. Yasuoka: Fibrinogenolytic activity of a novel trypsin-like enzyme found in human airway. J Med Invest 45, 77-86 (1998) (Pubitemid 128501269)
120. E. Bottcher, T. Matrosovich, M. Beyerle, H.D. Klenk, W. Garten, and M. Matrosovich: Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 80, 9896-9898 (2006) (Pubitemid 44435664)
121. R. Matsushima, A. Takahashi, Y. Nakaya, H. Maezawa, M. Miki, Y. Nakamura, F. Ohgushi, and S. Yasuoka: Human airway trypsin-like protease stimulates human bronchial fibroblast proliferation in a protease-activated receptor-2- dependent pathway. Am J Physiol Lung Cell Mol Physiol 290, L385-395 (2006)
122. M. Miki, Y. Nakamura, A. Takahashi, Y. Nakaya, H. Eguchi, T. Masegi, K. Yoneda, S. Yasuoka, and S. Sone: Effect of human airway trypsin-like protease on intracellular free Ca2+ concentration in human bronchial epithelial cells. J Med Invest 50, 95-107 (2003) (Pubitemid 36717343)
123. N. Beaufort, D. Leduc, H. Eguchi, K. Mengele, D. Hellmann, T. Masegi, T. Kamimura, S. Yasuoka, F. Fend, M. Chignard, and D. Pidard: The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions. Am J Physiol Lung Cell Mol Physiol 292, L1263-1272 (2007) (Pubitemid 47084872)
124. P.P. Sedghizadeh, S.R. Mallery, S.J. Thompson, L. Kresty, F.M. Beck, E.K. Parkinson, J. Biancamano, and J.C. Lang: Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression. Head Neck 28, 432-440 (2006) (Pubitemid 43673078)
125. C.G. Viloria, J.R. Peinado, A. Astudillo, O. Garcia- Suarez, M.V. Gonzalez, C. Suarez, and S. Cal: Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin. Br J Cancer 97, 201-209 (2007) (Pubitemid 47057477)
126. J.D. Hooper, A.L. Scarman, B.E. Clarke, J.F. Normyle, and T.M. Antalis: Localization of the mosaic transmembrane serine protease corin to heart myocytes. Eur J Biochem 267, 6931-6937 (2000)
127. Q. Wu, H.C. Kuo, and G.G. Deng: Serine proteases and cardiac function. Biochim Biophys Acta 1751, 82-94 (2005) (Pubitemid 41033298)
128. F. Wu and Q. Wu: Corin-mediated processing of proatrial natriuretic peptide in human small cell lung cancer cells. Cancer Res 63, 8318-8322 (2003) (Pubitemid 37549484)